Suchergebnisse - "Emberson, Jonathan"

PubPharm (9)

1

Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease

enthalten in: Hypertension (Dallas, Tex. : 1979) | 2017

von Herrington, W. | Staplin, N. | Judge, P. | +13

2

Interpretation of the evidence for the efficacy and safety of statin therapy

enthalten in: Lancet (London, England) | 2016

von Collins, R. | Reith, C. | Emberson, J. | +25

ErratumIn: Lancet. 2017 Feb 11;389(10069):602. - PMID 27567278

3

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD : Results of the Study of Heart and Renal Protection (SHARP)

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2016

von Mihaylova, B. | Schlackow, I. | Herrington, W. | +64

4

Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2016

von Morton, R. | Schlackow, I. | Staplin, N. | +9

CommentIn: Am J Kidney Dis. 2016 Jan;67(1):1-4. - PMID 26708191

5

Effects of lowering LDL cholesterol on progression of kidney disease

enthalten in: Journal of the American Society of Nephrology : JASN | 2014

von Haynes, R. | Lewis, D. | Emberson, J. | +65

6

The effect of lowering LDL cholesterol on vascular access patency : post hoc analysis of the Study of Heart and Renal Protection

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2014

von Herrington, W. | Emberson, J. | Staplin, N. | +62

7

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection) : a randomised placebo-controlled trial

enthalten in: Lancet (London, England) | 2011

von Baigent, C. | Landray, M. | Reith, C. | +148

CommentIn: Lancet. 2011 Jun 25;377(9784):2153-4. - PMID 21663950

8

Analyses of cancer data from three ezetimibe trials

enthalten in: The New England journal of medicine | 2008

von Peto, R. | Emberson, J. | Landray, M. | +4

CommentOn: N Engl J Med. 2008 Sep 25;359(13):1343-56. - PMID 18765433

9

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study

enthalten in: Journal of the American College of Cardiology | 2007

von Heart Protection Study Collaborative Group | Emberson, J. | Ng, L. | +4

1
[1]